Newmont Corporation (NEM)
Buenos Aires Exchange · Argentina · prices in ARS · close of 22 Oct 2026
Key indicators
| Last close | ARS 61,750.00 |
|---|---|
| 52-week range | 36,300.00 – 72,125.00 |
| Return, 1 month / 3 months | −9.3% / +23.6% |
| Return, 1 year / 3 years | +33.5% / +411.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 45 |
| Volatility (1 year) | 47.1% |
| Worst drawdown (1 year) | -29.3% |
| Average daily value traded | 91.45M ARS |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Newmont Corporation is a gold mining company based in Denver, Colorado, in the United States. It explores for, develops and operates mines that produce gold, along with copper, silver, zinc and lead as by-products. Its operations and projects are spread across North and South America, Australia and Africa, and its customers are mainly refiners, metal traders and industrial users of precious and base metals around the world.
On this site Newmont Corporation appears as a stock on the Buenos Aires Exchange (Argentina), code NEM, with prices in Argentine pesos (ARS). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Newmont Corporation (NEM) trades on the Buenos Aires Exchange in Argentina. It last closed at ARS 61,750.00 on 22 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 54 of 154 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 33.5% and over the last three months it rose 23.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Buenos Aires Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 8.0% | ||
| From 52-week high | -14.3% | ||
| Momentum | 76 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 23.6% | ||
| 6-month return | 13.0% | ||
| 12-month return, skipping the last month | 47.2% | ||
| Stability (higher is calmer) | 41 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 47.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.3% | ||
| Liquidity | 45 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 91.45M ARS | ||
| Zero-volume days | 3.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.7% |
|---|---|
| 1 month | −9.3% |
| 3 months | +23.6% |
| 6 months | +13.0% |
| 1 year | +33.5% |
| 3 years | +411.0% |
| 5 years | +2,304.4% |
Signals
| 50-day / 200-day average | 65,133.96 / 57,188.46 |
|---|---|
| Golden / death cross (60 days) | Golden, 40 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1,819.99 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Sep 2026 | USD 131.5172 |
| 27 May 2026 | USD 131.5172 |
| 3 Mar 2026 | USD 131.5172 |
| 26 Nov 2025 | USD 126.4578 |
| 4 Sep 2025 | USD 126.4578 |
| 27 May 2025 | USD 126.4578 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Buenos Aires Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.